Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

[Melatonin--clinical perspectives in prevention and therapy]

[Melatonin--clinical perspectives in prevention and therapy] Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • [Melatonin--clinical perspectives in prevention and therapy] Abstract Text:

    a suhnerA Suhner,r steffenR Steffen,

    Melatonin is a hormone produced by the pineal gland mainly during the night. Its primary function is to coordinate biological rhythms. It may be used for therapy of chronobiological disorders, such as occur in jet lag, shift work, blind persons or in specific forms of insomnia. Due to its anti-gonadotropic effect, melatonin in high doses has been used as a contraceptive. In-vitro and animal studies have demonstrated cancer inhibition, immun-stimulating and rejuvenating effects, but none of these claims have been confirmed in clinical studies. Melatonin used over a short period is not associated with significant side-effects, but the tolerability of long-term administration is unknown. As the products are not always of pharmaceutical quality, one should avoid uncontrolled use of melatonin.

    [Melatonin--clinical perspectives in prevention and therapy] Publishing Authors By Initials

    a suhnerA Suhner,r steffenR Steffen,

    For similar human activities: travel research abstracts see: human activities: travel research

    PUBMED ID PMID:

    MEDLINE DATE:

    [Melatonin--clinical perspectives in prevention and therapy] Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Therapeutische Umschau. Revue thérapeutique

    VOLUME: 54

    Page Numbers: 477-80

    Journal Abbreviation:

    ISSN: 0040-5930

    DAY: 12

    MONTH: Aug

    YEAR: 1997

    [Melatonin--clinical perspectives in prevention and therapy] Information

    Number of References:

    LANGUAGE: ger

    NlmUniqueID: 407224

    [Melatonin--clinical perspectives in prevention and therapy] Keywords Mesh Terms:

    KEYWORDS: Travel

    MESH TERMS: physiology

    Chemical & Substance for Abstract: [Melatonin--clinical perspectives in prevention and therapy] Information

    Substance Name: Melatonin

    Registry Number: 73-31-4

    Grant and Affiliation Information for [Melatonin--clinical perspectives in prevention and therapy]

    AFFILIATION: Institut für Sozial- und Präventivmedizin der Universität Zürich, Impfzentrum.

    Country: SWITZERLAND

    SWITZERLAND Research PublicationSWITZERLAND Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Ther Umsch

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Melatonin--clinical perspectives in prevention and therapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News